August Bioservices
US-based CDMO for end-to-end drug development
Project Engineer
About the job
- Provide engineering support for process equipment procurement and start-up at August Bioservices. This includes our Aseptic Filling Lines, Visual Inspection Machines, Label/Pack Lines, Ultrafiltration, Chromatography, Mixing Skids, Single Use Mixers, Buffer Prep Vessels, Temperature Control Units, Clean in Place Skids, etc..
- Drive results by owning and completing the subsequent projects including high quality technical writing within the required quality systems and meeting the project timelines to ensure the start-up schedule is not impacted.
- The Project Engineer will participate on project teams through all phases of engineering projects related to process equipment including conceptual design, detailed design, equipment procurement, construction, installation, start up, commissioning, validation, and qualification of facilities and/or equipment.
- Work with cross-functional teams for the design of equipment, consumables, and components, initiating and maintaining vendor relationships to meet design and construction timelines, and drive project schedules to meet milestone deliverables.
- Review design documentation from conceptual through detailed design, URS documents, and Engineering Turnover Packages, including specifications, component lists, operating manuals, and drawings for GMP process equipment and update as required.
- Participate in FATs, Commissioning and Start-up of process equipment related to manufacturing operations
- Provide troubleshooting for complex manufacturing equipment including formulation, fill/finish, packaging/inspection and serialization lines
- Experience interfacing with customer driven projects including tech transfer programs and process development
- Provide SME knowledge for CAPA and deviations that occur during the manufacturing process
- Support continuous improvement projects to increase line efficiency and reduce operating costs
- A bachelor’s degree in Chemical Engineering, Mechanical Engineering or related
- Minimum of 2 years relevant experience as a Process Engineer or similar function
- At least 2 years of experience in a GxP environment preferred
- Experience with Drug Substance and Drug Product Equipment (Aseptic Filling Lines, Visual Inspection Machines, Label/Pack Lines, Ultrafiltration, Chromatography, Mixing Skids, Single Use Mixers, Buffer Prep Vessels, Temperature Control Units, Clean in Place Skids, etc.)
- Excellent interpersonal and communication skills (verbal and written) are required. Expected to be able to present own work to peers and cross-functional managers and influence leadership decisions.
- Technical writing skills required.
- Must be able use his/her technical background to make informed project decisions and ensure timelines are met.
- Familiarity with Excel, Word, and PowerPoint are required.
- Ability to interact well with other groups and must be able to take ownership of and follow through on assignments. Must be able to drive results on multiple complex assignments simultaneously with minimal required direction from his/her supervisor.
- Ability to represent August Bioservices’ interests, objectives, and policies in a professional and responsible manner.
About the company
August Bioservices is a US-based CDMO offering end-to-end drug development and manufacturing from pre-clinical to commercial. It combines large-CDMO scale with a customer-focused hybrid model to serve startups and big pharma. It provides full development programs including research, development, testing, lab services, and sterile fill/finish under one integrated process, ensuring cGMP and FDA-quality standards. Its goal is to help clients bring safe, effective drugs to market efficiently through a seamless, integrated pathway.
Company Size
51-200
Company Stage
Series B
Total Funding
$88.6M
Headquarters
Nashville, Tennessee
Founded
2017
Get referred to August Bioservices
See people who can refer or advise you
Simplify's Take
What believers are saying
- Vial filling qualified in July 2026, unlocking throughput from the $60 million expansion.
- Series B funding in 2025 financed an additional high-speed vial suite and automation.
- August Bioservices' 2026 event calendar signals active business development across BIO, CPHI, and Contract Pharma.
What critics are saying
- Sterile injectable capacity takes roughly 30 months to qualify, delaying revenue from expansion.
- A single FDA contamination finding can halt lines, erase customer trust, and trigger recalls.
- Specialization in sterile injectables concentrates exposure if outsourcing demand shifts or major clients leave.
What makes August Bioservices unique
- Nashville campus offers sterile injectables, development, and manufacturing on one contiguous site.
- August Bio runs fully isolated vial, syringe, and IV bag lines with in-house analytics.
- The 2026 site integrates automated inspection, labeling, packaging, and serialization for faster releases.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Health Savings Account/Flexible Spending Account
Unlimited Paid Time Off
Flexible Work Hours
Remote Work Options
Paid Vacation
Paid Sick Leave
Paid Holidays
Sabbatical Leave
Hybrid Work Options
Stock Options
Company Equity
401(k) Retirement Plan
401(k) Company Match
Performance Bonus
Profit Sharing
Employee Stock Purchase Plan
Relocation Assistance
Employee Referral Bonus
Student Loan Assistance
Parental Leave
Family Planning Benefits
Fertility Treatment Support
Adoption Assistance
Childcare Support
Elder Care Support
Pet Insurance
Bereavement Leave
Professional Development Budget
Conference Attendance Budget
Training Programs
Tuition Reimbursement
Professional Certification Support
Mentorship Program
Wellness Program
Mental Health Support
Gym Membership
Commuter Benefits
Meal Benefits
Phone/Internet Stipend
Home Office Stipend
Legal Services
Employee Discounts
Company Social Events
Growth & Insights and Company News
6 month growth
↑ 1%1 year growth
↑ 1%2 year growth
↓ -1%August Bioservices,LLC, a contract development and manufacturing organization (CDMO) providing drug discovery, development, and pharmaceutical manufacturing ...
Impact of August Biopharmaceutical Layoffs: Over 500 Jobs Lost, Marking a 90% Decrease Compared to the Previous Year 09/10/2026
Jenn Adams named Healthcare Technology CEO of the Year. Published. March 18, 2026 At this year's NYC Awards Night, The Healthcare Technology Repo had the privilege of recognizing several exceptional leaders advancing innovation across healthcare technology. Congratulations to Jenn Adams, CEO of August Bioservices, on being named Healthcare Technology CEO of the Year. Jenn has led August Bioservices since its founding in 2020, building a contract development and manufacturing organization (CDMO) dedicated to sterile injectable therapies. Headquartered in Nashville, the company provides development and manufacturing services that help drug developers advance innovative therapies from early development through commercialization. Accepting the award, Jenn shared: "When we started our company five and a half years ago, we had a really clear goal and we set out to build a CDMO focused on sterile injectables that could truly serve as a partner to our clients, providing deep technical expertise and a state-of-the-art facility and equipment - all designed to help advance innovative therapies through development and commercialization. Our aspiration is to show up so fully for our clients that they cannot tell the difference anymore. It's indistinguishable to them who is on their team and who is on our team because we're working shoulder to shoulder to make sure the drug is advanced. And then we're bridging the innovation and bringing it to patients who need that innovation in the form of therapies." Please join The Healthcare Technology Repo in congratulating Jenn Adams on this well-deserved recognition. Picture: Jenn Adams speaks at NYC Awards Night
A new report from the Biotechnology Innovation Organization (BIO) and TEConomy Partners LLC finds Tennessee has emerged as a leading state for bioscience research and development, with bioscience RD accounting... The post Tennessee emerges as a leading state for bioscience RD appeared first on Teknovation.biz.
Like this story? Please share!News & Notes | UT Research Foundation welcomes four interns ETSU's Innovation Lab Director Dr. Audrey Depelteau served as a judge at last week's 2024 SelectUSA Investment Summit.From Knoxville:To promote the commercialization of University of Tennessee (UT) innovations and to help train the next generation of commercialization professionals, the UT Research Foundation (UTRF) recently welcomed three new interns and one returning intern across its Knoxville and Memphis offices.In Knoxville, Andrea Gutierrez-Cortez and Lauren Williams , rising second-year law students at UT, Knoxville (UTK), joined the team as Commercialization Analysts. Jacob Hale is returning for his second year with UTRF as a Senior Commercialization Analyst. Hale is a rising third-year law student, while Gutierrez-Cortez completed her bachelor’s degree in human biology at the University of California, San Diego, and Williams majored in biomedical engineering at UTK.and , rising second-year law students at UT, Knoxville (UTK), joined the team as Commercialization Analysts. is returning for his second year with UTRF as a Senior Commercialization Analyst. Hale is a rising third-year law student, while Gutierrez-Cortez completed her bachelor’s degree in human biology at the University of California, San Diego, and Williams majored in biomedical engineering at UTK